ESC 365 - Guideline-directed therapy at discharge is important in patients with heart failure and atrial fibrillation

ESC Premium Access

Guideline-directed therapy at discharge is important in patients with heart failure and atrial fibrillation

Session: Poster Session 1 - Treatment of the chronic heart failure

Topic: Pharmacotherapy

Speaker: Assistant Professor J. Son (Wonju, KR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Assistant Professor Jung Woo Son

Wonju Christian Hospital, Wonju (Korea (Republic of))

0 follower

9 more presentations in this session

Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

Speaker: Doctor A. Kozynacka (Krakow, PL)

Effect of sacubitril-valsartan in reducing physical frailty in patients with advanced heart failure in waiting list for heart transplantation

Speaker: Doctor G. Benincasa (Naples, IT)

Use of sacubitril-valsartan in an extensive long term follow up cohort in real life

Speaker: Doctor A. Garcia Quintana (Palmas de Gran Canaria, Las, ES)

Changes in glycated hemoglobin in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan

Valsartan reduces level of soluble ST2 and left ventricle remodeling in patients with dual chamber pacemaker

Speaker: Mrs E. Radzik (Zabrze, PL)

Access the full session

Poster Session 1 - Treatment of the chronic heart failure

Speakers: Assistant Professor J. Son, Doctor A. Kozynacka, Doctor G. Benincasa, Doctor A. Garcia Quintana, Mrs E. Radzik

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources